Spironolactone Tablet, Film Coated
Product Images NDC 55154-3556

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 55154-3556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone depicted as a molecular diagram showing the steroid core with attached functional groups, including a lactone ring and a thioester substituent.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A survival probability Kaplan-Meier curve comparing spironolactone versus placebo over a period of up to 42 months. The y-axis shows probability, while the x-axis shows months. The spironolactone group (n=822) shows higher survival probability than the placebo group (n=841). A log-rank p-value less than 0.001 is indicated.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot chart showing hazard ratios (HR) with 95% confidence intervals (CI) across various subgroups for spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium level, digoxin use, ACE inhibitor use, and beta blocker use. The chart indicates comparative effectiveness outcomes with spironolactone labeled on the left and placebo on the right of the vertical line.*
FDA Label Image

25mg Bag Label (8ea4a249 3e16 4017 9daf 2ee294ea4667 00)

25mg Bag Label (8ea4a249 3e16 4017 9daf 2ee294ea4667 00)
Label for spironolactone tablets USP 25 mg, film-coated, oral dosage form, containing 10 tablets. The label includes storage instructions, a warning that the package is not child resistant and intended for institutional use, and distributor information for Major Pharmaceuticals and Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.